Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.
about
Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent.Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a.Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil chemotaxis to complement split product C5a.Studies of human C5a as a mediator of inflammation in normal human skin.Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement.Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.Pulmonary injury induced by C3a and C5a anaphylatoxinsComparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy.Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.Acute inflammation. A review.Modulation of human eosinophil polymorphonuclear leukocyte migration and functionThe regulatory role of divalent cations in human granulocyte chemotaxis. Evidence for an association between calcium exchanges and microtubule assembly.Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetateIn vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresisExpression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragmentsAntiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactionsLIM kinase 1 promotes endothelial barrier disruption and neutrophil infiltration in mouse lungs.Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.Chemotactic activity in dialyzable transfer factor.The regulation of complement activity by pharmacologic agents.Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.A factor in serum lowers resistance and opens tight junctions of MDCK cells.Fast deactivation of guinea-pig isolated ileum to C5adesArg: a possible cyclic AMP-dependent mechanism.Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.Evidence of complement catabolism in experimental acute pancreatitis.The isolation and characterization of bovine C4a, an activation fragment of the fourth component of complement.Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response.Hormonal control of lysosomal enzyme release from human neutrophils. Effects of autonomic agents on enzyme release, phagocytosis, and cylic nucleotide levels.Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.Suppression of leukocyte chemotaxis by human IgA myeloma components.Synergism between inflammatory mediators in vivo. Induction of airway hyperresponsiveness to C3a in the guinea pig.
P2860
Q33556024-B901D245-6AC7-448F-A4EA-1F48D29C4C6AQ33774345-821644CB-02DD-4634-A35F-B25707992751Q34428863-DAC31EA6-A421-4B7F-84F7-A7BAC675FEE4Q34484070-71D916AE-7C20-40A8-8AD8-E06199855379Q34526448-1B3C42E8-1BD6-42E4-AAE2-64D6EB3267CDQ34530621-066C478B-106D-4425-A7C2-03DAE5A4726DQ34739161-9607294F-48E1-48D8-8A00-4047FB03AB3BQ35586919-723A0DA6-D9AC-4968-9296-523CD1159810Q35863270-61E589E3-EE08-4D6F-B303-2A1814A3013FQ35863608-A3BADAE1-C566-40EA-8FE6-F15E4B47D7E6Q35885820-63D64C13-6FA2-4978-B152-A006813766FFQ36076876-94039DEE-EEF0-4076-A0AC-4CB5CC5B2A3DQ36078173-A9221701-9E14-47F6-8110-120A45999D93Q36196127-F83E6A9D-9314-4FB8-B65E-8CE3446F3DDDQ36197048-878EA20E-D428-4404-9E8F-EA4A3C68496FQ36335817-15054AE4-7FE7-4A5D-AC2A-D3E6A01513C8Q36347899-3CDB7446-6B00-4BD5-9B29-5761C8C783FAQ36350691-3F78C288-90FA-4A85-AE9A-B08F2BACCBB3Q37032224-30B59026-8B5C-4AE1-8E31-793B56C4845CQ37039731-943773B5-A8F0-4971-8333-21CD7A6A9D07Q37431647-12E8D0C2-5C5F-46E3-8494-EFDC948F8845Q40123049-93D74561-94DA-4D7E-9723-A04597D84B34Q40690752-3533B81F-694A-4273-B008-8BAEF01D657CQ41719230-6256ED77-4D09-42A5-84B7-235563EE1087Q41738683-3B25AEAD-7465-4F46-A6AC-DAE6838D93C2Q41843614-2284CAD6-BA08-4A4B-B878-F1BC0936088EQ41882579-B16F7BED-93EE-40A7-ACB5-7C67133902AFQ41889442-2885CFA2-C571-43E1-954B-7502D72BD7C2Q42260495-8C5EC22D-A1E4-4CB1-810F-C020DF5CB409Q42735386-A1F5D46D-C45D-4B3F-875E-7E6F87FCC869Q42837012-A6AF3868-388C-4405-887E-D31EB82911ABQ42936090-D927838F-1951-403F-AF6C-7521B8B25278Q42941080-5BB61FF7-DDE9-4171-8F07-EE34D71A4FA5Q46728123-E03DD994-00AE-41F6-8E3B-34A0DB762192
P2860
Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Formation of C3a and C5a anaph ...... the anaphylatoxin inactivator.
@en
Formation of C3a and C5a anaph ...... the anaphylatoxin inactivator.
@nl
type
label
Formation of C3a and C5a anaph ...... the anaphylatoxin inactivator.
@en
Formation of C3a and C5a anaph ...... the anaphylatoxin inactivator.
@nl
prefLabel
Formation of C3a and C5a anaph ...... the anaphylatoxin inactivator.
@en
Formation of C3a and C5a anaph ...... the anaphylatoxin inactivator.
@nl
P2860
P356
P1476
Formation of C3a and C5a anaph ...... the anaphylatoxin inactivator.
@en
P2093
Müller-Eberhard HJ
Vallota EH
P2860
P304
P356
10.1084/JEM.137.5.1109
P407
P577
1973-05-01T00:00:00Z